Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Cambrex Corporation    CBM   US1320111073

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
20.25(c) 20.51(c) 20.64(c) 21.6(c) 21.81 Last
301 856 182 150 202 396 155 252 43 371 Volume
-1.56% +1.28% +0.63% +4.65% +0.97% Change
More quotes
Company
Cambrex Corp. is a life sciences company. It provides products, services and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies its products and services worldwide to innovator and generic pharmaceutical companies. It products... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Chart CAMBREX CORPORATION
Duration : Period :
Cambrex Corporation Technical Analysis Chart | CBM | US1320111073 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 352 M
EBIT 2014 47,9 M
Net income 2014 31,4 M
Debt 2014 -
Yield 2014 -
Sales 2015 386 M
EBIT 2015 60,5 M
Net income 2015 40,7 M
Debt 2015 -
Yield 2015 -
PER 2014 20,64
PER 2015 15,88
Capi. / Sales 2014 1,79x
Capi. / Sales 2015 1,64x
Capitalization 632 M
More Financials
Latest news on CAMBREX CORPORATION
07/14 CAMBREX : Manufacturing Facility Completes Successful US FDA Pre-Approval Inspec..
07/12 CAMBREX : Manufacturing Facility Completes Successful US FDA Inspection
07/12 CAMBREX : Manufacturing Facility Completes Successful US FDA Pre-Approval Inspec..
07/09 CAMBREX : NeoStem Appoints Steven M. Klosk to Board of Directors
07/08 CAMBREX : NeoStem Appoints Steven M. Klosk to Board of Directors
06/09 PAREXEL : Cambrex Names James Winschel to Board
06/04 CAMBREX : James F. Winschel Appointed to the Board of Directors of Cambrex Corpo..
06/03 PAREXEL : Cambrex Appoints James Winschel to Board
05/29 CAMBREX : Change in Directors or Principal Officers (form 8-K)
05/29 CAMBREX : to Present at Upcoming Investor Conferences
05/23 CAMBREX : To Present At Upcoming Investor Conferences In June
05/22 CAMBREX : Manufacturing Facility Completes Successful US FDA Inspection
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Technical analysis
Income Statement Evolution
Cambrex Corporation : Income Statement Evolution
More Financials
EPS Revisions
Cambrex Corporation : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF